Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.
2.

The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy.

Lee DY, Sugden B.

Oncogene. 2008 May 1;27(20):2833-42. Epub 2007 Nov 26.

PMID:
18037963
3.

Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.

Dirmeier U, Neuhierl B, Kilger E, Reisbach G, Sandberg ML, Hammerschmidt W.

Cancer Res. 2003 Jun 1;63(11):2982-9.

4.

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A.

J Virol. 2008 Oct;82(20):10175-87. doi: 10.1128/JVI.00321-08. Epub 2008 Aug 6.

5.
6.

The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.

Pratt ZL, Zhang J, Sugden B.

J Virol. 2012 Apr;86(8):4380-93. doi: 10.1128/JVI.06966-11. Epub 2012 Feb 8.

7.

Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngeal carcinoma.

Hsiao JR, Chang KC, Chen CW, Wu SY, Su IJ, Hsu MC, Jin YT, Tsai ST, Takada K, Chang Y.

Cancer Res. 2009 May 15;69(10):4461-7. doi: 10.1158/0008-5472.CAN-09-0277. Epub 2009 May 12.

8.

Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.

Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseño C, Gires O, Kieser A, Eick D, Sugden B, Hammerschmidt W.

Oncogene. 2005 Mar 3;24(10):1711-7.

PMID:
15674340
9.

The Latent Membrane Protein 1 (LMP1).

Kieser A, Sterz KR.

Curr Top Microbiol Immunol. 2015;391:119-49. doi: 10.1007/978-3-319-22834-1_4. Review.

PMID:
26428373
10.

Human cytomegalovirus infection activates and regulates the unfolded protein response.

Isler JA, Skalet AH, Alwine JC.

J Virol. 2005 Jun;79(11):6890-9.

11.

Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.

Zhou H, Guo W, Long C, Wang H, Wang J, Sun X.

Biochem Biophys Res Commun. 2015 Jan 16;456(3):815-20. doi: 10.1016/j.bbrc.2014.12.023. Epub 2014 Dec 13.

PMID:
25511707
12.
13.
14.
15.
16.
17.

Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.

Motsch N, Pfuhl T, Mrazek J, Barth S, Grässer FA.

RNA Biol. 2007 Nov;4(3):131-7.

PMID:
18347435
18.

Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.

Fåhraeus R, Palmqvist L, Nerdstedt A, Farzad S, Rymo L, Laín S.

EMBO J. 1994 Dec 15;13(24):6041-51.

19.

Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

D'Souza BN, Edelstein LC, Pegman PM, Smith SM, Loughran ST, Clarke A, Mehl A, Rowe M, Gélinas C, Walls D.

J Virol. 2004 Feb;78(4):1800-16.

20.

Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.

Lai KY, Chou YC, Lin JH, Liu Y, Lin KM, Doong SL, Chen MR, Yeh TH, Lin SJ, Tsai CH.

J Virol. 2015 Jun;89(11):5968-80. doi: 10.1128/JVI.00168-15. Epub 2015 Mar 25.

Supplemental Content

Support Center